nLiven PR™

N-Liven PR product shot
Price: $578
ADD TO CART
Price: $2409
ADD TO CART

Evaluate HPL

Media that empowers your cells

nLiven PR™ is a human platelet lysate (hPL) manufactured using a unique pathogen reduction process that reduces risks and improves downstream cell performance.

nLiven PR uses a unique GMP compliance pathogen-reduced process. Designed to meet your
needs for the evolving global regulations and challenging development milestones, nLiven PR is
your tool to develop therapeutics by providing safety, reproducibility, reliable supply and
compliance.

nLIVEN PR Performance

  • Proprietary E-Beam irradiation process
  • Improves cell culture and cell expansion compared with supplements such as FBS and Chemically Defined media
  • Highly consistent across lots allowing for reproducible manufacturing of cell product
  • Performance in both 2D and 3D culture systems;

Quality

  • Manufactured under a certified ISO9001:2015 Quality Management System
  • Certificate of Analysis Documenting testing for Sterility, Endotoxin, Mycoplasma
  • BM-MSC growth verification assay for Clinical Grade product
  • Certificates of Origin and Compliance available
  • Sexton Biotechnologies supports regulatory filings and audits of the process or facility for
    nLiven

Regulatory

  • U.S. FDA DMF, PMDA regenerative medicine eligible, approval in EU clinical studies
  • Manufactured from expired apheresis platelet units sourced from AABB-accredited and FDA-registered blood centres
  • Raw materials meet FDA and AABB requirements for platelet transfusion
  • Full donor traceability
  • TSE Statements, COC and Non-animal component statements available